Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO2Life® (M101)
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 146, 110421
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Cerebral Vasoactivity and Oxygenation with Oxygen Carrier M101 in RatsJournal of Neurotrauma, 2017
- Coronaviruses: An Overview of Their Replication and Pathogenesis2015
- Reactive Oxygen Species in Endothelial Function – From Disease to Adaptation –Circulation Journal, 2015
- In vivo biodistribution and oxygenation potential of a new generation of oxygen carrierJournal of Biotechnology, 2014
- Dose-Ranging Study of the Performance of the Natural Oxygen Transporter HEMO2Life in Organ PreservationArtificial Organs, 2014
- Supplementation With a New Therapeutic Oxygen Carrier Reduces Chronic Fibrosis and Organ Dysfunction in Kidney Static PreservationAmerican Journal of Transplantation, 2011
- Arenicola marina extracellular hemoglobin: a new promising blood substituteBiotechnology Journal, 2006
- Haem, haem oxygenase and ferritin in vascular endothelial cell injuryNephrology Dialysis Transplantation, 2003
- Quaternary Structure of the Extracellular Haemoglobin of the Lugworm Arenicola marinaEuropean Journal of Biochemistry, 1997
- Ventilation and respiratory gas exchanges of the lugworm Arenicola marina (L.) as functions of ambient PO2 (20–700 torr)Respiration Physiology, 1984